111 related articles for article (PubMed ID: 20647701)
21. [Chemotherapy in elderly patients with hematological malignancies].
Ohnishi K
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1586-90. PubMed ID: 21996952
[TBL] [Abstract][Full Text] [Related]
22. Cardiac involvement in patients with hematologic malignancies.
Allegra A; Alonci A; Russo S; Cannavò A; Penna G; D'Angelo A; Bellomo G; Musolino C
J Investig Med; 2010 Oct; 58(7):859-74. PubMed ID: 20683345
[TBL] [Abstract][Full Text] [Related]
23. EPHA3 as a novel therapeutic target in the hematological malignancies.
Keane N; Freeman C; Swords R; Giles FJ
Expert Rev Hematol; 2012 Jun; 5(3):325-40. PubMed ID: 22780212
[TBL] [Abstract][Full Text] [Related]
24. Farnesyltransferase inhibition in hematologic malignancies: the clinical experience with tipifarnib.
Martinelli G; Iacobucci I; Paolini S; Ottaviani E
Clin Adv Hematol Oncol; 2008 Apr; 6(4):303-10. PubMed ID: 18496498
[TBL] [Abstract][Full Text] [Related]
25. Management of hematological malignancies in patients affected by renal failure.
Niscola P; Vischini G; Tendas A; Scaramucci L; Giovannini M; Bondanini F; Romani C; Brunetti GA; Cartoni C; Cupelli L; Ferrannini M; Perrotti A; Del Poeta G; Palumbo R; de Fabritiis P
Expert Rev Anticancer Ther; 2011 Mar; 11(3):415-32. PubMed ID: 21417855
[TBL] [Abstract][Full Text] [Related]
26. Specialty pharmacy for hematologic malignancies.
Fajardo S; Zook F; Dotson E
Am J Health Syst Pharm; 2016 Jun; 73(11):797-809. PubMed ID: 27126835
[TBL] [Abstract][Full Text] [Related]
27. Targeted therapies for the myeloid leukaemias.
Maslak P; Scheinberg D
Expert Opin Investig Drugs; 2000 Jun; 9(6):1197-205. PubMed ID: 11060736
[TBL] [Abstract][Full Text] [Related]
28. [Novel conventional therapies in onco-hemathology].
Baleydier F; Domenech C; Thomas X
Bull Cancer; 2011 Aug; 98(8):901-13. PubMed ID: 21865110
[TBL] [Abstract][Full Text] [Related]
29. Predicting the effect of transcription therapy in hematologic malignancies.
Melnick A
Leukemia; 2005 Jul; 19(7):1109-17. PubMed ID: 15858614
[TBL] [Abstract][Full Text] [Related]
30. Immune modulatory agents in hematopoietic malignancies.
Idler I; Bhattacharya N; Döhner H; Stilgenbauer S; Mertens D
Cancer Treat Rev; 2011; 37 Suppl 1():S2-7. PubMed ID: 21645972
[TBL] [Abstract][Full Text] [Related]
31. Emerging new anticancer biological therapies in 2013 (haematological malignancies).
Plawny L; Ries F
Curr Opin Oncol; 2014 May; 26(3):363-70. PubMed ID: 24663027
[TBL] [Abstract][Full Text] [Related]
32. [Recent research progress of rhythmic chemotherapy in patients with hematological neoplasm].
Yu M; Zhou F; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):281-3. PubMed ID: 21569717
[No Abstract] [Full Text] [Related]
33. Exploring old drugs for the treatment of hematological malignancies.
Gan F; Cao B; Wu D; Chen Z; Hou T; Mao X
Curr Med Chem; 2011; 18(10):1509-14. PubMed ID: 21428892
[TBL] [Abstract][Full Text] [Related]
34. Targeted therapy in haematological malignancies.
Hamilton A; Gallipoli P; Nicholson E; Holyoake TL
J Pathol; 2010 Mar; 220(4):404-18. PubMed ID: 20041451
[TBL] [Abstract][Full Text] [Related]
35. Targeted therapy for haematological malignancies: clinical update from the American Society of Hematology, 2004.
Haas M; Lonial S
Expert Opin Investig Drugs; 2005 Sep; 14(9):1161-9. PubMed ID: 16144500
[TBL] [Abstract][Full Text] [Related]
36. Oral chemotherapy agents in the treatment of leukaemia.
Geller RB; Dix SP
Drugs; 1999; 58 Suppl 3():109-18. PubMed ID: 10711849
[TBL] [Abstract][Full Text] [Related]
37. Advances in the treatment for haematological malignancies.
Piccaluga PP; Martinelli G; Baccarani M
Expert Opin Pharmacother; 2006 Apr; 7(6):721-32. PubMed ID: 16556088
[TBL] [Abstract][Full Text] [Related]
38. To adhere or not to adhere: Rates and reasons of medication adherence in hematological cancer patients.
Hall AE; Paul C; Bryant J; Lynagh MC; Rowlings P; Enjeti A; Small H
Crit Rev Oncol Hematol; 2016 Jan; 97():247-62. PubMed ID: 26412718
[TBL] [Abstract][Full Text] [Related]
39. New targets for hematologic malignancies.
Bradner J
Clin Adv Hematol Oncol; 2013 Jun; 11(6):375-6. PubMed ID: 24472807
[No Abstract] [Full Text] [Related]
40. Biological therapy for pediatric malignancy: current perspectives.
Agarwal B
Indian J Pediatr; 2008 Aug; 75(8):839-44. PubMed ID: 18769896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
